BCYC
Bicycle Therapeutics Plc - ADR

869
Mkt Cap
$344.09M
Volume
13.00
52W High
$13.66
52W Low
$6.03
PE Ratio
-1.90
BCYC Fundamentals
Price
$6.90
Prev Close
$6.67
Open
$6.68
50D MA
$6.84
Beta
1.03
Avg. Volume
247,379.23
EPS (Annual)
-$2.91
P/B
0.77
Rev/Employee
$115,704.40
Loading...
Loading...
News
all
press releases
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Receives Consensus Recommendation of "Hold" from Brokerages
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC - Get Free Report) has been given a consensus rating of "Hold" by the thirteen research firms that are presently covering the stock, MarketBeat...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026
Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today...
Business Wire·10d ago
News Placeholder
Bicycle Therapeutics (NASDAQ:BCYC) CEO Sells $70,210.00 in Stock
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC - Get Free Report) CEO Kevin Lee sold 10,325 shares of the company's stock in a transaction dated Friday, January 2nd. The shares were sold at an...
MarketBeat·16d ago
News Placeholder
Bicycle Therapeutics (NASDAQ:BCYC) CEO Kevin Lee Sells 10,989 Shares
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC - Get Free Report) CEO Kevin Lee sold 10,989 shares of the business's stock in a transaction dated Monday, January 5th. The stock was sold at an...
MarketBeat·16d ago
News Placeholder
Bicycle Therapeutics (NASDAQ:BCYC) COO Alistair Milnes Sells 3,244 Shares
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC - Get Free Report) COO Alistair Milnes sold 3,244 shares of the company's stock in a transaction on Friday, January 2nd. The stock was sold at an...
MarketBeat·16d ago
News Placeholder
Insider Selling: Bicycle Therapeutics (NASDAQ:BCYC) COO Sells 3,416 Shares of Stock
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC - Get Free Report) COO Alistair Milnes sold 3,416 shares of the company's stock in a transaction dated Monday, January 5th. The shares were sold at...
MarketBeat·16d ago
News Placeholder
Alethia Young Sells 3,289 Shares of Bicycle Therapeutics (NASDAQ:BCYC) Stock
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC - Get Free Report) CFO Alethia Young sold 3,289 shares of the stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an...
MarketBeat·16d ago
News Placeholder
Insider Selling: Bicycle Therapeutics (NASDAQ:BCYC) CFO Sells 4,334 Shares of Stock
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC - Get Free Report) CFO Alethia Young sold 4,334 shares of the firm's stock in a transaction dated Monday, January 5th. The shares were sold at an...
MarketBeat·16d ago
News Placeholder
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Receives Average Rating of "Hold" from Brokerages
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC - Get Free Report) has received a consensus recommendation of "Hold" from the thirteen brokerages that are covering the firm, MarketBeat Ratings...
MarketBeat·27d ago
News Placeholder
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Receives Average Recommendation of "Hold" from Analysts
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC - Get Free Report) has earned a consensus rating of "Hold" from the thirteen research firms that are currently covering the company, MarketBeat...
MarketBeat·27d ago
<
1
2
...
>

Latest BCYC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.